Emerald Health Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Emerald Health Pharmaceuticals's estimated annual revenue is currently $3.3M per year.
- Emerald Health Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Emerald Health Pharmaceuticals has 21 Employees.
- Emerald Health Pharmaceuticals grew their employee count by -19% last year.
Emerald Health Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
Emerald Health Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Emerald Health Pharmaceuticals?
Emerald Heath Pharmaceuticals is a biotech company developing medicines based on first-in-class cannabinoid science and technology to treat diseases with significant unmet medical needs, including multiple sclerosis, systemic sclerosis (a form of scleroderma), Parkinson's disease and Huntington's disease. Any statements regarding Emerald Health Pharmaceuticals' Regulation A+ financing shall not be deemed an offer to buy or offer to sell securities. Offers will be made only to qualified investors who have reviewed the Company’s offering circular. View here: https://investehp.com/wp-content/uploads/2019/07/Supplement-No.-2-merged-with-Supplement-Final-OC.pdf. References/Sources: - National Multiple Sclerosis Society - Parkinson’s Foundation - Huntington’s Disease Society of America - Scleroderma Foundation - Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025 Research and Markets Report - Scleroderma Diagnostics and Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024 Transparency Market Research Report - Parkinson's Disease Therapeutics Market Global Industry Analysis Size, Share, Growth ,Trends, and Forecasts, 2017 To 2025 Transparency Market Research Report - Opportunity Analyzer: Huntington's Disease Opportunity Analysis and Forecast to 2024 Research and Markets Report
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | -9% | N/A |
#2 | $4M | 21 | -5% | N/A |
#3 | $2.1M | 21 | N/A | N/A |
#4 | $1.1M | 21 | N/A | N/A |
#5 | $3.3M | 21 | -12% | N/A |